Covidien ($COV) nailed down a 510(k) clearance, this time for a group of next-generation Nellcor pulse oximetry monitoring devices--a regulatory win that will likely ...
Leading health care products company, Covidien plc. (COV) recently won the U.S. Food and Drug Administration (:FDA) 510(k) approval as well as the European Economic Area (EEA) CE Mark clearance for ...
BOULDER, Colo.--(BUSINESS WIRE)--Every year, nearly 7,200 infants are born in the United States with a Critical Congenital Heart Disease (CCHD). 1 It is a condition that is often easily detectable and ...
On June 21, Covidien plc (COV), global innovator and manufacturer of healthcare products, announced the launch of Nellcor SpO 2 single parameter module in North America, European Economic Area (EEA) ...
Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...
<0> CovidienRhonda Luniak, 303-305-2263Vice PresidentR&MS CommunicationsorBruce Farmer, 508-452-4372Vice PresidentPublic RelationsorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor ...
BOULDER, Colo.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today ...
Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE)-- Covidien, a leading global provider of healthcare products and recognized ...
Global innovator and manufacturer of health care products, Covidien plc (COV), has announced the U.S. Food and Drug Administration’s (:FDA) clearance for its Nellcor Bedside SpO 2 Patient Monitoring ...
Covidien, a leading global provider of health care products and recognized innovator in patient monitoring and respiratory care devices, today announced CE Mark and the launch of the Nellcor™ Portable ...
DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the ...
Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the integration of its Nellcor™ OxiMax™ oximetry system into Philips IntelliVue and M-Series patient monitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback